Immuno Analyzers Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Immuno Analyzers Market By Product (Chemiluminescence Immunoassay Analyzers, Radioimmunoassay Analyzers, Immunofluorescence Analyzers, ELISA Analyzers, Consumables), By Application (Oncology, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disease, Infectious Disease Testing),  Based on end user (Biotechnological Firms, Research Organizations, Diagnostic Centers, Others)  and  Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global immuno analyzers market size is expected to reach USD 39.5 billion by 2027 from USD 27.8 billion in 2021, at a CAGR of 6.8% during the forecast period. Immunoassay analyzers are the instruments which are used in clinical settings, hospitals or maybe the research organizations to run the biochemical tests to detect the concentration of samples. The market for immuno analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating growth prospects for the global immuno analyzers market. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardisation, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in global immuno analyzers market are focusing on the new product developments and launches to strengthen their position. For instance In September 2014, Sysmex Corp. has launched Automated, compact Immunoassay System HISCL 800 for immunochemistry testing for increasingly diverse needs. Furthermore, companies also adapting the strategies such as acquisitions and collaboration to increase their product portfolio and market share. For instance, in March 2016, Diasorin S.p.A. has entered into the agreement to acquire Quest’s Focus Diagnostics, Inc. molecular diagnostic and immunodiagnostic products business.


Immuno Analyzers Market

MARKET SUMMARY
-
6.8%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 6.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Immuno Analyzers Market Report

  • The report on global immuno analyzers market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, application, end-user and geography.
  •  immuno analyzers market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Abbott Laboratories (U.S.)
  • Hoffmann-La Roche AG (Switzerland)
  • Biomerieux, Inc. (France)
  • Diasorin S.P.A (Italy)
  • Becton Dickinson & Company (U.S.)
  • Siemens AG (Germany)
  • Bio Rad Laboratories Inc. (U.S.)
Drivers And Restraints

Immuno Analyzers Market

Global immune analyzers market is primarily driven by adaptation of the automated instruments in the research and other commercial organizations, especially in developed countries. In addition, growing prevalence of the chronic conditions, infectious diseases and R&D investments in biotechnological companies around the world. Furthermore, advancements in the immune analyzers such as advent of portable immune assay analyzers and new product launches are expected to boost the market growth over the forecast period. However, high cost of devices and lack of skilled professionals are expected to hamper the market growth over the forecast period.


North-America got significant share

Immuno Analyzers Market

Geographically, global immuno analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America immune analyzers market is expected to grow at notable rates owing to the technological advancements and presence of key market players in the region. In addition, recent product launches and collaboration of various organizations in advancing the biotechnology to diagnose and treat diseases projected to boost the market share in the region. For Instance, Abbot Laboratories has launched Automated Immunoassay instrument Architect i1000SR. Europe immune analyzers market projected to have significant market share due to the presence of key market players and adaptation of automated instruments and increased fundings in biotechnological firms. Asia Pacific region projected to have lucrative market growth opportunity owing to the increase in the prevalence of chronic and infectious diseases. The countries such as India and China expected to contribute significant share in regional market owing to increase in the R&D investment by the companies and adaptation of automated instruments in many organizations

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

In September 2017 Siemens got CE Mark and launched its Atellica Solution flexible, scalable, automation-ready immunoassay and chemistry analyzer


Key

Key Features of the Report

Immuno Analyzers Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Description

The global immuno analyzers market size is expected to reach USD 39.5 billion by 2027 from USD 27.8 billion in 2021, at a CAGR of 6.8% during the forecast period. Immunoassay analyzers are the instruments which are used in clinical settings, hospitals or maybe the research organizations to run the biochemical tests to detect the concentration of samples. The market for immuno analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating growth prospects for the global immuno analyzers market. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardisation, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in global immuno analyzers market are focusing on the new product developments and launches to strengthen their position. For instance In September 2014, Sysmex Corp. has launched Automated, compact Immunoassay System HISCL 800 for immunochemistry testing for increasingly diverse needs. Furthermore, companies also adapting the strategies such as acquisitions and collaboration to increase their product portfolio and market share. For instance, in March 2016, Diasorin S.p.A. has entered into the agreement to acquire Quest’s Focus Diagnostics, Inc. molecular diagnostic and immunodiagnostic products business.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX